According to a recent LinkedIn post from HistoSonics, the company plans to engage surgeons and oncology specialists at the Society of Surgical Oncology conference in Phoenix, AZ, from March 5–7. The post highlights a focus on histotripsy education through new sessions tailored to advanced practice providers, residents, and fellows.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The company’s LinkedIn post outlines a dedicated dinner event, described as a peer-driven forum for current and emerging histotripsy users, featuring speakers from MD Anderson Cancer Center at Cooper and NE Georgia Medical Center. The forum centers on “Histotripsy in Practice,” suggesting an emphasis on real-world clinical adoption and physician networking.
As shared in the post, HistoSonics intends to showcase its Edison Histotripsy System at booth 821 on the exhibition floor, while also noting that use outside liver applications is currently limited to clinical investigations. For investors, this visibility at a major surgical oncology meeting may support clinician awareness, early adopter engagement, and future demand, but the regulatory and clinical scope remains constrained, potentially moderating near-term revenue impact.